Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT03646058
PHASE3

Add-on Buprenorphine at Analgesic Doses for the Treatment of Severe Suicidal Ideas During a Major Depressive Episode

Sponsor: Centre Hospitalier Universitaire de Nīmes

View on ClinicalTrials.gov

Summary

This study aims at investigating if adjunctive buprenorphine at low dose to treatment as usual is effective in reducing severe suicidal ideas in major depressive episode, and at determining the most effective dose.

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

180

Start Date

2021-10-10

Completion Date

2027-01

Last Updated

2025-08-21

Healthy Volunteers

No

Interventions

DRUG

Buprenorphine

Buprenorphine, 0.4mg pills, sublingual

DRUG

Placebo

Placebo pills, sublingual, specifically made to mimick buprenorphine pills

Locations (9)

Ch Perrens

Bordeaux, France, France

CHU Bicêtre

Le Kremlin-Bicêtre, France

Hospices Civils de Lyon

Lyon, France

CAPPA Jacques PREVERT

Nantes, France

CHU Nîmes

Nîmes, France

CH Sainte-Anne

Paris, France

CH Henri Laborit

Poitiers, France

Chu Toulouse Hopital Purpan

Toulouse, France

CHU de Tours

Tours, France